within Pharmacolibrary.Drugs.ATC.J;

model J04AM01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J04AM01</td></tr><td>route:</td><td></td></tr><tr><td>n-compartments</td><td>0</td></tr></table><p>Streptomycin and isoniazid are antibacterial agents used in combination for the treatment of tuberculosis (TB). Streptomycin is an aminoglycoside antibiotic, primarily used in severe cases, and isoniazid is a first-line antitubercular agent. The combination is approved and recommended for TB treatment, especially in cases of resistance or intolerance to other drugs.</p><h4>Pharmacokinetics</h4><p>No direct population or compartment pharmacokinetic model for the fixed-dose combination of streptomycin and isoniazid with ATC code J04AM01 is published. The individual pharmacokinetic parameters for each drug are well known, but no combined PK model is referenced in the literature.</p><h4>References</h4><ol><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=\"https://doi.org/10.1007/s40272-013-0017-5\">10.1007/s40272-013-0017-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529866/\">https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Pouplin, T, et al., &amp; Day, JN (2016). Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis. <i>BMC infectious diseases</i> 16 144–None. DOI:<a href=\"https://doi.org/10.1186/s12879-016-1470-x\">10.1186/s12879-016-1470-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27039088/\">https://pubmed.ncbi.nlm.nih.gov/27039088</a></p></li><li><p>Verrest, L, et al., &amp; Dorlo, TPC (2021). Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review. <i>Clinical pharmacokinetics</i> 60(9) 1149–1169. DOI:<a href=\"https://doi.org/10.1007/s40262-021-01031-z\">10.1007/s40262-021-01031-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34060020/\">https://pubmed.ncbi.nlm.nih.gov/34060020</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J04AM01;
